Is Revolution Medicines, Stock a Good Investment?
Revolution Medicines, Investment Advice | RVMDW |
- Examine Revolution Medicines,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Revolution Medicines,'s leadership team and their track record. Good management can help Revolution Medicines, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Revolution Medicines,'s business and its evolving consumer preferences.
- Compare Revolution Medicines,'s performance and market position to its competitors. Analyze how Revolution Medicines, is positioned in terms of product offerings, innovation, and market share.
- Check if Revolution Medicines, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Revolution Medicines,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Revolution Medicines, Warrant stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Revolution Medicines, Warrant is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Revolution Medicines, Stock
Researching Revolution Medicines,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Revolution Medicines, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Revolution Medicines,'s research are outlined below:
| Revolution Medicines, is way too risky over 90 days horizon | |
| Revolution Medicines, has some characteristics of a very speculative penny stock | |
| Revolution Medicines, appears to be risky and price may revert if volatility continues | |
| Revolution Medicines, has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (592.23 M). | |
| Revolution Medicines, generates negative cash flow from operations |
Revolution Medicines, Quarterly Liabilities And Stockholders Equity |
|
Revolution Medicines,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.24) | (0.25) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.23) | (0.25) | |
| Return On Equity | (0.26) | (0.28) |
Determining Revolution Medicines,'s profitability involves analyzing its financial statements and using various financial metrics to determine if Revolution Medicines, is a good buy. For example, gross profit margin measures Revolution Medicines,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Revolution Medicines,'s profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Revolution Medicines,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Revolution Medicines, Warrant. Check Revolution Medicines,'s Beneish M Score to see the likelihood of Revolution Medicines,'s management manipulating its earnings.
Evaluate Revolution Medicines,'s management efficiency
The company has return on total asset (ROA) of (0.1866) % which means that it has lost $0.1866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2933) %, meaning that it generated substantial loss on money invested by shareholders. Revolution Medicines,'s management efficiency ratios could be used to measure how well Revolution Medicines, manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.25 in 2025. Return On Capital Employed is likely to drop to -0.3 in 2025. At this time, Revolution Medicines,'s Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 18.4 M in 2025, whereas Intangible Assets are likely to drop slightly above 47.5 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.50 | 14.18 | |
| Tangible Book Value Per Share | 13.08 | 13.73 | |
| Enterprise Value Over EBITDA | (10.05) | (10.55) | |
| Price Book Value Ratio | 3.24 | 3.08 | |
| Enterprise Value Multiple | (10.05) | (10.55) | |
| Price Fair Value | 3.24 | 3.08 | |
| Enterprise Value | 6.9 B | 7.3 B |
Management at Revolution Medicines, focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Beta 1.457 |
Basic technical analysis of Revolution Stock
As of the 28th of March, Revolution Medicines, holds the Semi Deviation of 15.78, risk adjusted performance of 0.0167, and Coefficient Of Variation of 11746.5. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Revolution Medicines,, as well as the relationship between them. Please check Revolution Medicines, standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Revolution Medicines, is priced some-what accurately, providing market reflects its current price of 0.0939 per share. As Revolution Medicines, appears to be a penny stock we also advise to check out its total risk alpha numbers.Understand Revolution Medicines,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Revolution Medicines,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0167 | |||
| Market Risk Adjusted Performance | 0.1762 | |||
| Mean Deviation | 14.81 | |||
| Semi Deviation | 15.78 | |||
| Downside Deviation | 20.15 | |||
| Coefficient Of Variation | 11746.5 | |||
| Standard Deviation | 20.67 | |||
| Variance | 427.12 | |||
| Information Ratio | 0.0093 | |||
| Jensen Alpha | 0.1917 | |||
| Total Risk Alpha | 0.8062 | |||
| Sortino Ratio | 0.0095 | |||
| Treynor Ratio | 0.1662 | |||
| Maximum Drawdown | 92.92 | |||
| Value At Risk | (29.41) | |||
| Potential Upside | 38.46 | |||
| Downside Variance | 406.2 | |||
| Semi Variance | 249.08 | |||
| Expected Short fall | (23.45) | |||
| Skewness | 0.6684 | |||
| Kurtosis | 0.366 |
| Risk Adjusted Performance | 0.0167 | |||
| Market Risk Adjusted Performance | 0.1762 | |||
| Mean Deviation | 14.81 | |||
| Semi Deviation | 15.78 | |||
| Downside Deviation | 20.15 | |||
| Coefficient Of Variation | 11746.5 | |||
| Standard Deviation | 20.67 | |||
| Variance | 427.12 | |||
| Information Ratio | 0.0093 | |||
| Jensen Alpha | 0.1917 | |||
| Total Risk Alpha | 0.8062 | |||
| Sortino Ratio | 0.0095 | |||
| Treynor Ratio | 0.1662 | |||
| Maximum Drawdown | 92.92 | |||
| Value At Risk | (29.41) | |||
| Potential Upside | 38.46 | |||
| Downside Variance | 406.2 | |||
| Semi Variance | 249.08 | |||
| Expected Short fall | (23.45) | |||
| Skewness | 0.6684 | |||
| Kurtosis | 0.366 |
Consider Revolution Medicines,'s intraday indicators
Revolution Medicines, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Revolution Medicines, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 0.0939 | |||
| Day Typical Price | 0.0939 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) | |||
| Relative Strength Index | 41.87 |
Revolution Stock media impact
Far too much social signal, news, headlines, and media speculation about Revolution Medicines, that are available to investors today. That information is available publicly through Revolution media outlets and privately through word of mouth or via Revolution internal channels. However, regardless of the origin, that massive amount of Revolution data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Revolution Medicines, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Revolution Medicines, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Revolution Medicines,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Revolution Medicines, alpha.
Revolution Medicines, Corporate Management
| Jack Anders | Chief Officer | Profile | |
| Erin Graves | Senior Relations | Profile | |
| Walter Reiher | Chief Officer | Profile | |
| Margaret JD | Chief Officer | Profile | |
| Michael Fischbach | Academic Board | Profile |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.